4//SEC Filing
Vuori Kristiina MD 4
Accession 0002007919-24-000047
CIK 0002007919other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:14 PM ET
Size
6.5 KB
Accession
0002007919-24-000047
Insider Transaction Report
Form 4
Vuori Kristiina MD
Director
Transactions
- Purchase
Common Stock
2024-09-11$15.07/sh+6,457$97,307→ 13,776 total - Purchase
Common Stock
2024-09-10$15.00/sh+179$2,685→ 7,319 total
Footnotes (1)
- [F1]The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Inhibrx Biosciences, Inc.
CIK 0002007919
Entity typeother
Related Parties
1- filerCIK 0001612627
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 5:14 PM ET
- Size
- 6.5 KB